Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
Kazuko Koike(Okayama University), Kazuhide Yamamoto(Kurume University Medical Center), Akinobu Takaki(Okayama University), Masashi Utsumi(Okayama University), Daisuke Sato(Okayama University), Hidenori Shiraha(Kawasaki Medical School), Tetsuya Yasunaka(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Yuzo Umeda(Okayama University), Toshiyoshi Fujiwara(Okayama University), Fusao Ikeda(Okayama University), Susumu Shinoura(Okayama University), Takahito Yagi(Okayama University), Hiroshi Sadamori(Okayama University), Yoshiaki Iwasaki(Okayama University), Yasuhiro Miyake(High Energy Accelerator Research Organization), Ryuichi Yoshida(Okayama University)
Cited by 23
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Linoleic Acid, Other Fatty Acids, and the Risk of Stroke
|Stroke|2002|249
A new approach for measuring the muon anomalous magnetic moment and electric dipole moment
|Progress of Theoretical and Experimental Physics|2019|239